HHS axes Moderna’s $590M pandemic bird flu vaccine contract, ending funding for late-phase trials
The Department of Health and Human Services has axed a $590 million contract with Moderna, raising doubts about how the biotech will fund late-phase development of a pandemic bird flu vaccine.
The Department of Health and Human Services has axed a $590 million contract with Moderna, raising doubts about how the biotech will fund late-phase development of a pandemic bird flu vaccine.
